Home > Animal Health & Nutrition > Veterinary Services > Dog Dewormers Market

Dog Dewormers Market Size

  • Report ID: GMI11674
  • Published Date: Oct 2024
  • Report Format: PDF

Dog Dewormers Market Size

The global dog dewormers market size was valued at around USD 1.4 billion in 2023 and is estimated to grow at a 9.5% CAGR from 2024 to 2032. Increased pet ownership and a rising focus on zoonotic diseases are driving the growth of the market.

 

The growing trend of pet ownership is a key driver behind the expansion of the market. Factors contributing to this increase in pet ownership include changing lifestyles and urbanization, where more people seek companionship through pets, especially dogs. Additionally, the American Pet Products Association (APPA) reported that 66% of U.S. households owned pets in 2023, while global spending on veterinary care and products reached USD 35.9 billion in 2022. This combination of factors continues to fuel the growth of the market as pet owners prioritize preventive care to ensure their pets remain healthy.
 

Furthermore, the rising focus on zoonotic diseases, which are transmitted from animals to humans, is driving the growth of the dog dewormers market as awareness increases about the risks posed by parasitic infections in pets. Worms such as roundworms and hookworms can spread from dogs to humans, leading to serious health concerns. As a result, pet owners and veterinarians are placing greater emphasis on regular deworming to prevent the transmission of these diseases, further boosting the demand for dog dewormers.
 

Dog dewormers are veterinary medications specifically formulated to eliminate or prevent parasitic worm infestations in dogs, such as roundworms, hookworms, tapeworms, and whipworms. These treatments help protect dogs from the health issues caused by these parasites and reduce the risk of zoonotic disease transmission to humans.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The industry was valued at approximately USD 1.4 billion in 2023 and is projected to grow at a 9.5% CAGR from 2024 to 2032, driven by increased pet ownership and a rising focus on zoonotic diseases.

Tablets and chewable treats generated the highest revenue of USD 768.6 million in 2023. Their popularity stems from their convenience, ease of administration, and high compliance rates among pet owners.

In 2023, North America's market recorded USD 513.3 million in revenue and is anticipated to grow at a CAGR of 9.1% between 2024 and 2032. The high pet ownership rates in the U.S. and Canada drive this demand, as owners seek to keep their pets free from parasites.

Some of the prominent market participants include Bayer AG, Beaphar, Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Durvet Animal Health Products, Elanco Animal Health Incorporated, Jurox Pty Limited, Merck & Co., Inc., Ourofino Animal Health, and PetIQ, LLC.

Dog Dewormers Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 152
  • Countries covered: 23
  • Pages: 100
 Download Free Sample